logo
logo

Foxo Technologies Inc. Announces Closing Of $10 Million Investment To Launch Foxo Life And Continue Commercializing Epigenetic Biomarker Technology

Apr 07, 2021•over 4 years ago
Minneapolis

Description

FOXO Technologies Inc. ("FOXO") today announced that it has closed a $10 million investment led by healthcare and technology investor Bespoke Growth Partners, Inc. The investment represents the first external capital FOXO has received and brings its total funding to $40 million.

Company Information

Company

Foxo

Location

Minneapolis, Minnesota, United States

About

FOXO Technologies Inc. uses AI-driven bioinformatics and microarray technologies to develop and commercialize epigenetic biomarkers of health and aging. FOXO provides insurers, health researchers, and life science companies with laboratory services, microarray design, and AI-driven bioinformatics software solutions for generating novel health-based insights into lifespan. For more information about FOXO, visit www.foxotechnologies.com or email [email protected].